Lactobacillus buchneri with hypoglycemic activity and application of lactobacillus buchneri in fermented milk
By mixing Lactobacillus PB6 isolated from Guizhou sour soup with traditional starter cultures, a fermented milk with hypoglycemic activity was prepared. This solved the problem of insufficient application of Lactobacillus PB6 in existing technologies and achieved efficient blood sugar regulation and intestinal health effects.
Patent Information
- Application Number
- CN202610322325.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-03-17
- Publication Date
- 2026-06-09
AI Technical Summary
Existing research on the hypoglycemic function of Lactobacillus brucellosis is relatively limited, and its application in dairy products is also limited. Most studies focus on a single mechanism and have not conducted comprehensive research. Existing drugs have side effects when treating type 2 diabetes.
Lactobacillus brucellosis PB6 was isolated from Guizhou sour soup. It has a high inhibition rate of α-amylase and α-glucosidase and can promote GLP-1 secretion. When it is mixed with Streptococcus thermophilus and Lactobacillus delbrueckii in fermented milk, fermented milk with hypoglycemic activity is prepared.
Fermented milk exhibits high inhibition rates of α-amylase and α-glucosidase, promotes GLP-1 secretion, improves liver glycogen metabolism, maintains intestinal flora balance, and possesses excellent antioxidant and antibacterial capabilities. It also boasts superior sensory quality and rheological properties, is safe and non-toxic, and is suitable as a raw material for functional foods.